12 Days of Hope Submitted by: Dr. Cynthia Hawkins, @CHawkinsLab "New scientific advances are bringing real hope to the brain cancer community, with breakthroughs that would have seemed impossible only a few years ago. IDH inhibitors are showing promise for patients with IDH-mutant gliomas by directly targeting the mutation that drives tumor growth, offering the potential for slower progression and better quality of life. At the same time, new therapeutic approaches for DIPG, one of the most devastating childhood brain cancers - are emerging through focused ultrasound - enhanced drug delivery, targeted molecular therapies, and innovative immunotherapies designed to reach tumors previously considered untreatable. These developments highlight why research matters: every study, every experiment, brings us one step closer to giving patients better options and better outcomes. This insight unlocks new treatment possibilities, challenges old assumptions, and moves us closer to therapies that are more effective and less harmful. My work has been accelerated thanks to support from Brain Cancer Canada, which provides high-impact funding that allows researchers like me to pursue bold ideas and rapidly test feasibility of promising new approaches. Their investment has helped move discoveries from the lab toward the clinic more quickly, ensuring that scientific progress translates into real hope for the people who need it most." #12DaysOfHope #DrCynthiaHawkins

We are proud to stand with @CHawkinsLab🩶